Are you currently at the International Conference on Prenatal Diagnosis and Therapy (ISPD)? Visit us at Booth 108 this afternoon for a sweet treat and a chat with our experts. Discover how we're revolutionizing the standard in prenatal care!
BillionToOne
Biotechnology Research
Menlo Park, California 17,466 followers
We push the boundaries of molecular diagnostics through quantitative technologies.
About us
BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible. Our proprietary molecular counting platform can accurately count DNA molecules at the single-count level to help improve disease detection.
- Website
-
https://www.billiontoone.com
External link for BillionToOne
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Menlo Park, California
- Type
- Privately Held
- Founded
- 2016
Locations
-
Primary
1035 O'Brien Drive
Menlo Park, California 94025, US
Employees at BillionToOne
Updates
-
We're thrilled to be at ISPD and can't wait to connect with you! Come visit us at Booth 108 to discover how we're revolutionizing prenatal care. Why Visit Our Booth? ⏺ Learn from the Experts: Our team is ready to chat with you about our groundbreaking updates. ⏺ ACOG Guideline on Fetal Antigen NIPT: Learn more about the updated guideline and how it impacts patient care ⏺ RhoGAM Shortage Notice: Get insights into the updated ACOG notice and the use of RhD NIPT in the general RhD- population. Visit Booth 108 to learn more! #ISPD2024 #PrenatalCare #UNITYComplete #NIPT #FetalMedicine #HealthcareInnovation International Society for Prenatal Diagnosis
-
Exciting things to come with Premji Invest - US! Your investment and partnership will help us continue to transform the diagnostics landscape. Thank you!
Thrilled to announce that PI led the Series D round for BillionToOne. Excited to partner with Oguzhan Atay, PhD, David Tsao and team as they build the definitive molecular diagnostic company. Their innovative technology and execution in a hyper competitive space has been nothing short of incredible. Tk Kurien Sandesh Patnam Akshay Rai Andrew Chang
-
BillionToOne continues to be highlighted in NYC! Thank you to NYSE for showcasing our Series D announcement! #NYSE #BillionToOne #SeriesD #PremjiInvest #prenatal #oncology #UNITY #Northstar
-
A huge thank you to Nasdaq for highlighting BillionToOne on the Times Square tower today! 💥 $130 million in an oversubscribed, upsized Series D funding 🌟 Over $1B+ Valuation 🚀 $0M to $125M ARR in the last ~4 years 🩺 The future of healthcare is here! #BillionToOne #UNITYComplete #Northstar #prenatalhealth #oncology #Nasdaq #SeriesD
-
Today we announced the successful completion of a Series D funding round, raising $130 million and bringing our total valuation to over $1B. The round was led by Premji Invest and Neuberger Berman, with participation from our existing investors. The funds will be allocated to further scale our prenatal screening and oncology diagnostics businesses, expanding the reach of our innovative tests powered by our proprietary Quantitative Counting Templates (QCTs) technology. Over 500,000 patients have benefited from our cutting-edge tests to date. We appreciate the support of our investors and the dedication of our team as we work towards our mission to make molecular diagnostics more powerful, efficient, and accessible for all. Read our press release here ➡ https://lnkd.in/gj5fF9hH Claire Rychlewski from Axios wrote about the news here ➡ https://lnkd.in/gd-FeKhh #oncology #prenatalhealth #moleculardiagnostics #BillionToOne #UNITY #Northstar #Axios
Leading Molecular Diagnostics Company BillionToOne Raises $130 Million in Oversubscribed Series D Funding Over $1B+ Valuation
prnewswire.com
-
🏆 We are excited to announce that our very own CEO, Oguzhan Atay, PhD has been recognized by Slice of Healthcare as a Top Leader in Digital Health! A huge congrats to Oguzhan and the other honorees! View the list here ➡ https://lnkd.in/eh5cuuEr #SoHCTopDigitalHealthLeaders #BillionToOne
-
UNITY Complete will be at the Julian Wells Lectureship in Dallas today! Learn about our groundbreaking first-of-its-kind testing for fetal RhD. We look forward to meeting you! #RhD #UNITYComplete #prenatalhealth
-
Thank you Clinical Trials Arena for highlighting Northstar Select and Dr. Gary Palmer! "Patients with low levels of ctDNA could benefit most from BillionToOne’s NorthStar Select. BillionToOne analyzed clinical samples from 182 patients with advanced forms of solid tumors using its NorthStar Select or comparator assays. The company found its assay detected 46% more SNVs/Indels and of those, 69% were clinically actionable. “The great majority of variants that we found that the other assays did not were in the low variant allele fraction, the very low range. This more sensitive test could find things that other assays could not,” BillionToOne’s Chief Medical Officer Dr Gary Palmer told Medical Device Network. " Read more here ➡ https://lnkd.in/erRCV4u7 #NorthstarSelect #Oncology #ClinicalTrials